Ingalls & Snyder LLC Sells 235 Shares of Globe Life Inc. (NYSE:GL)

Ingalls & Snyder LLC lessened its holdings in shares of Globe Life Inc. (NYSE:GL) by 0.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 164,571 shares of the company’s stock after selling 235 shares during the period. Ingalls & Snyder LLC’s holdings in Globe Life were worth $18,353,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in GL. Nuance Investments LLC grew its holdings in shares of Globe Life by 155.6% during the third quarter. Nuance Investments LLC now owns 1,138,978 shares of the company’s stock worth $120,629,000 after purchasing an additional 693,346 shares during the last quarter. Swedbank AB bought a new stake in shares of Globe Life during the fourth quarter worth $52,414,000. International Assets Investment Management LLC lifted its stake in shares of Globe Life by 15,398.7% during the third quarter. International Assets Investment Management LLC now owns 336,631 shares of the company’s stock valued at $356,530,000 after acquiring an additional 334,459 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Globe Life by 22.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,519,675 shares of the company’s stock valued at $160,949,000 after acquiring an additional 277,108 shares during the period. Finally, Segall Bryant & Hamill LLC lifted its stake in shares of Globe Life by 78.5% during the third quarter. Segall Bryant & Hamill LLC now owns 290,515 shares of the company’s stock valued at $30,768,000 after acquiring an additional 127,764 shares during the period. Institutional investors own 81.61% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on GL shares. Evercore ISI raised Globe Life from an “in-line” rating to an “outperform” rating and upped their price target for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Jefferies Financial Group upped their price target on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research note on Tuesday, December 10th. Truist Financial upped their price target on Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, October 25th. BMO Capital Markets started coverage on Globe Life in a research note on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price target on the stock. Finally, Morgan Stanley upped their price target on Globe Life from $123.00 to $125.00 and gave the company an “equal weight” rating in a research note on Tuesday. Five research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, Globe Life presently has a consensus rating of “Moderate Buy” and an average price target of $133.10.

Globe Life Trading Up 0.0 %

NYSE:GL opened at $121.51 on Thursday. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00. The business’s 50-day moving average price is $113.98 and its two-hundred day moving average price is $107.66. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $10.20 billion, a price-to-earnings ratio of 10.17 and a beta of 0.81.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share for the quarter, beating the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, equities analysts expect that Globe Life Inc. will post 13.57 earnings per share for the current year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were given a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date of this dividend was Monday, January 6th. Globe Life’s dividend payout ratio is currently 8.03%.

Insider Transactions at Globe Life

In other news, CEO James Matthew Darden sold 24,890 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the sale, the chief executive officer now owns 38,973 shares of the company’s stock, valued at $4,735,998.96. This trade represents a 38.97 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Mark A. Blinn sold 3,000 shares of the firm’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now directly owns 5,122 shares in the company, valued at approximately $579,964.06. This represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 64,678 shares of company stock valued at $7,454,412 over the last 90 days. 1.51% of the stock is owned by company insiders.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.